We feel like a lame duck on the markets.
CORT (ISIN: US2183521028)
Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive antagonist at the glucocorticoid receptor (GR).
Gain over the last quarter: +36.3 %
Fair value: $ 16.5
Discount: 20%
Yield: N/A
Outperformer
Mind the valuta risk:
No comments:
Post a Comment